Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH)

NCT05397470 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

260

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Facioscapulohumeral Muscular Dystrophy (FSHD)

Interventions

DRUG: Losmapimod
DRUG: Placebo oral tablet

Sponsor

Fulcrum Therapeutics